ClinicalTrials.govpublic full text
A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors
solid tumor, non small cell lung cancer, renal cell carcinoma, triple negative breast cancer, ido-1 inhibitor, ido1 inhibitor, ido inhibitor, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 980957
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.